Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction

Scandinavian Cardiovascular Journal, Supplement

Volumn 31, Issue 46, 1997, Pages 31-40

  Holm, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN RECEPTOR;

ARTICLE; HYPOXIA; LUNG CIRCULATION; LUNG VASOCONSTRICTION; PRIORITY JOURNAL; ADULT; ANIMAL; ANOXIA; BLOOD; CHILD; DRUG ANTAGONISM; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY HYPERTENSION; REVIEW; SWINE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ADULT; ANIMALS; ANOXIA; CHILD; ENDOTHELIN-1; ENDOTHELIN-3; ENDOTHELINS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; PULMONARY CIRCULATION; RECEPTORS, ENDOTHELIN; SWINE; VASOCONSTRICTION;

EID: 0030628879     PISSN: 14017458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (231)

1. Abman SH, Chatfield BA, Rodman DM, Hall SL, McMurtry IV. Maturational changes in endothelium-derived relaxing factor activity of ovine pulmonary arteries in vitro. Am J Physiol. 1991;260(4):L280-L285.
2. Adnot S, Raffestin B, Eddahibi S, Braquet P, Chabrier PE. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest. 1991;87:155-162.
3. Allen KM, Wharton J, Polak JM, Haworth SG. A study of nerves containing peptides in the pulmonary vasculature of healthy infants and children and of those with pulmonary hypertension. Br Heart J 1989;62:353-360.
4. Allen SW, Chatfield BA, Koppenhafer AM, Schaffer S, Wolfe RR, Abman SH. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Am Rev Resp Dis 1993;148:519-522.
5. Änggård E, Galton S, Rae G, Thomas R, McLoughlin L, de Nucci G, Vane JR. The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharmacol 1989;13:S46-49.
6. Arai H, Hori S, Aramori I, Ohkubo H, Nakanischi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-732.
7. Arai H, Nakao K, Takaya K, Hosoda K, Ogawa Y, Nakanishi S, Imura H. The human endothelin-B receptor gene: structural organization and chromosomal assignment. J Biol Chem 1993;268:3463-3470.
8. Ashutosh K, Mead G, Dunsky M, Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and cor pulmonale. Am Rev Resp Dis 1983;127(4):399-404.
9. Barer G, Emery C, Stewart A, Bee D, Howard P. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. J Physiol 1993;463:1-16.
10. Bax WA, Saxena PR. The current edothelin receptor classification: time for reconsideration. Trends Pharmacol Sci 1994;15:379-386.
11. Bevegård S, Holmgren A, Jonsson B. Circulatory studies in well trained athletes at rest and during heavy exercise, with special reference to stroke volume and the influence of body position. Acta Physiol Scand 1963;57:26-50.
12. Blitzer ML, Loh E, Roddy MA, Stamler JS, Creager MA. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J Am Coll Card 1996:28:591-596.
13. Bonvallet ST, Zamora MR, Hasunuma K, Sato K, Hanasato N, Anderson D, Sato K, Stelzner TJ, BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am J Phys 1994;266(4 Pt 2):H1327-1331.
14. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest 1990;85:587-590.
15. 2 receptor antagonism on pulmonary vasoconstrictor responses. Pediatr Res 1989;26:175-179.
16. Brashers VL, Peach MJ , Rose CE. Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium dependent relaxation. J Clin Invest 1988;82:1495-1502.
17. Burbach JPH, Meijer OC. The structure of neuropeptide receptors. Eur J Pharmacol Mol Pharmacol 1992;227:1-18.
18. Carville C, Raffestin B, Eddahibi S, Blouquit Y, Adnot S. Loss of endothelium-dependent relaxation in proximal pulmonary arteries from rats exposed to chrome hypoxia: effects of in vivo and in vitro supplementation with L-arginine. J Cardiovasc Pharmacol 1993;22:889-896.
19. Cassin S, Dawes GS, Mott JC, Ross BB, Strang LB. The vascular resistance of the fetal and newly ventilated lung of the lamb. J Physiol 1964;171:61-79.
20. Cernacek P, Stewart DJ. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Comm 1989;161:562-567.
21. Chang H, Wu GJ, Wang SM, Hung CR. Plasma endothelin levels and surgically correctable pulmonary hypertension. Ann Thorac Surg 1993;55:450-458.
22. Chen SJ, Meng Q, Yano M, Oparil S, Chen YF. Endothelin A receptor antagonism prevents acute hypoxia induced pulmonary hypertension in rats (Abstract). FASEB J 1993;7: A649.
23. Chester AH, O'Neil GS, Allen SP, Luu TN, Tadjkarimi S, Yacoub MH. Effect of endothelin on normal and diseased human coronary arteries. Eur J Clin Invest 1992;22:210-213.
24. 2 mimietic in rat heart smooth muscle cells. Biochim Biophys Acta 1996;1313:1-5.
25. A receptor antagonist. J Cardiovasc Pharmacol 1994;24(4):587-594.
26. Clarke JG, Larkin SW, Benjamin N, Keogh BE, Chester A, Davies GJ, Taylor KM, Maseri A. Endothelin-1 is a potent long-lasting vasoconstrictor in dog peripheral vasculature in vivo. J Cardiovasc Pharmacol 13 1989;Suppl 5:S211-S212.
27. B receptor mediates both vasodilatation and vascoconstriction in vivo. Biochem Biophys Res Commun 1992;186:857-863.
28. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504-509.
29. Corrin B. Pulmonary hypertension in the lungs. In: Corrin B, ed. Systemic pathology (3 rd edn). London: Churchill Livingstone, 1990;289-298.
30. Daily PO, Dembitsky WP, Peterson KL, Moser KM. Modifications of techniques and early results of pulmonary thromboendarterectomy for chronic pulmonary embolism. J Thorac Cardiovasc Surg 1987;93:221-223.
31. B receptors in human vascular smooth muscle. J Cardiovasc Pharmacol 1993;22(Suppl. 8):S22-S25.
32. De Leval M. Ventricular septal defects. In: Stark J, de Leval, M ed. Surgery for congenital heart defects. Philadelphia: WB Saunders 1994:355-372.
33. De Mey JG, Vanhoutte PM. Anoxia and endothelium-dependent reactivity of the canine femoral artery. J Phys 1983;335:65-74.
34. De Mey JG, Vanhoutte PM. Contribution of the endothelium to the response of anoxia in the canine femoral artery. Arch Int Pharmacodyn Ther 1981;253:325-326.
35. De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C. Warner TD. Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797-9800.
36. Deleuze PH, Adnot S, Shiiya N, Roudot Thoraval F, Eddahibi S, Braquet P, Chabrier PE, Loisance DY. Endothelin dilates bovine pulmonary circulation and reverses hypoxic pulmonary vasoconstriction. J Cardiovasc Pharmacol. 1992;19:354-360.
37. Deng AY, Martin LL, Balwierczak JL, Jeng AY, Purification and characterization of an endothelin degradation enzyme from rat kidney. J Biochem 1994;115(1):120-125.
38. Dev D, Howard S. Chronic obstructive disease. In: Morice AH ed. Clinical pulmonary hypertension. London: Portland press 1995:116-128.
39. A-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in the rat. Am J Physiol 1995;269:L690-697.
40. Dieguez G, Garcia JL, Fernandez N, Garcia-Villalon AL, Monge L, Gomez B. Cerebrovascular and coronary effects of endothelin-1 in the goat. Am J Physiol 1992;263(4 Pt 2):R834-R839.
41. Dinerman JL, Lowenstein CJ, Snyder SH. Molecular mechanisms of nitric oxide regulation. Circ Res 1993;3:217-222.
42. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, Wallwork J. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. New Engl J Med 1991;324:1539-1547.
43. Dinh-Xuan AT, Higenbottam TW, Wallwork J. Relationship between chronic hypoxia and in vitro pulmonary relaxation mediated by endothelium-derived relaxing factors in human chronic obstructive lung disease. Angiology 1992;43:350-356.
44. B receptor antagonist, BQ-788. Br J Pharmacol 1994;113:1257-1262.
45. Douglas SA, Vickery-Clark LM, Ohlstein EH. Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ-123. Br J Pharmacol 1993;108:418-421.
46. Dzau VJ, Gibbons GH. Endothelium and growth factors in vascular remodeling of hypertension. Hypertension 1991;18(Suppl III):115-120.
47. Eddahibi S, Raffestin B, Clozel M, Levame M, Adnot S. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. Am J Physiol 1995;268:H828-835.
48. Eddahibi S, Springall D, Mannan M, Carville C, Chabrier PE, Levame M, Raffestin B, Polak J, Adnot S. Dilator effect of endothelins in pulmonary circulation: changes associated with chronic hypoxia. Am J Physiol 1993;265:L571-580.
49. Elshourbagy NA, Korman DR, Wu HL, Sylvester DR, Lee JA, Nuthalaganti P, Bergsma DJ, Kumar CS, Nambi P. Molecular characterization and regulation of the human endothelin receptors. J Biol Chem 1993;268:3873-3879.
50. Emil S, Kanno S, Berkeland J, Kosi M, Atkinson J. Sustained vasodilatation after inhaled nitric oxide for hypoxic pulmonary hypertension in swine. J Pediatr Surg 1996;31:389-393.
51. Emori T, Hirata Y, Imai T, Ohta K, Kanno K, Eguchi S, Marumo F. Cellular mechanism of thrombin on endothelin-1 biosynthesis and release in bovine endothelial cell. Biochem Pharmacol 1992;44:2409-2411,
52. Emori T, Hirata Y, Marumo F. Endothelin-3 stimulates prostacyclin production in cultured bovine endothelial cells. J Cardiovasc Pharmacol. 1991a;17:5140-5142.
53. Emori T, Hirata Y, Ohta K, Kanno K, Eguchi S, Imai T, Shichiri M, Marumo F. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension 1991b;18(2):165-70.
54. Emoto N, Yanagisawa M. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 1995;270: 15262-15268.
55. Enoki T, Miwa S, Sakamoto A, Minowa T, Komuro T, Kobayashi S, Ninomiya H, Masaki T. Long-lasting activation of cation current by low concentration of endothelin-1 in mouse fibroblasts and smooth muscle cells of rabbit aorta. Br J Pharmacol 1995;115:479-485.
56. Euler US von, Liljestrand G. Observation on the pulmonary arterial pressure in the cat. Acta Physiol Scand 1946;12:301-320.
57. Ferri C, Bellini C, De Angelis C, De Siati L, Perrone A, Properzi G, Santucci A. Circulating endothelin-1 concentrations in patients with chronic hypoxia. J Clin Pathol 1995;48:519-524.
58. Fishman AP. Chronic cor pulmonale. State of the art. Am Rev Respir Dis 1976;114:775-794.
59. Fowlkes DM, Mullis NT, Comeau CM, Crabtree GR. Potential basis for regulation of the coordinately expressed fibrinogen genes: homology in the 5′ flanking regions. Proc Natl Acad Sci USA 1984;81(8):2313-2316.
60. Fox WW, Duara S. Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr 1983;103:505-514.
61. Franco-Cereceda, A. Endothelin- and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries in vitro. Br J Pharmacol 1989:97:968-972.
62. Franco-Cereceda A. Calcitonin gene-related peptide and human epicardial coronary arteries: presence, release and vasodilator effects. Br J Pharmacol 1991;102:506-510.
63. Franco-Cereceda A, Matran R, Lou Y-P, Lundberg JM. Occurrence and effects of endothelin in guinea-pig cardiopulmonary tissue. Acta Physiol Scand 1990;137:539-547.
64. Franco-Cereceda A, Barr G, Öwall A, Liska J, Lundberg JM. Is endotlielin-1 release at reperfusion of the ischaemic human heart due to cold-induced displacement of endotlielin from binding sites? Eur J Pharmacol 1995;279:105-107.
65. Fredén F. Pulmonary blood flow in acute lung injury and regional hypoxia. Effect of modulating the nitric oxide-guanylate cyclase system. Acta Universitatis Upsaliensis. Comprehensive Summaries Uppsala Dissertations Faculty Med 1997;681:1-40
66. Frostell CG, Blomqvist HG, Hedenstierna G, Lundberg JM, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilatation. Anesthesiology 1993;78:427-435.
67. B receptors in rats. Biochem Biophys Res Commun 1994a;199:1461-1465.
68. Fukuroda T, Kobayashi M, Ozaki S, Yano M, Miyauchi T, Onizuka M, Sugishita Y, Goto K, Nishikibe M. Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J Appl Physiol 1994b;76:1976-1982.
69. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
70. Fyhrquist F, Saijonmaa O, Metsarinne K, Tikkanen I, Rosenlof K, Tikkanen T. Raised plasma endothelin-I concentration following cold pressor test. Biochem Biophys Res Commun 1990;169:217-221.
71. Gasic S, Wagner OF, Vierhapper H, Nowotny P, Waldhaüsl W. Regional hemodynamic effects and clearance of endothelin-1 in humans: renal and peripheral tissues may contribute to the overall disposal of the peptide. J Cardiovasc Pharmacol 1992;19:176-180.
72. Giaid A, Polak JM, Gaitonde V, Hamid QA, Moscoso G, Legon S, Uwanogho D, Roncalli M, Shinmi O, Sawamura T, et al. Distribution of endothelin-like immunoreactivity and mRNA in the developing and adult human lung. Am J Respir Cell Mol Biol 1991;4:50-58.
73. Giaid A, Stewart DJ, Michael RP. Endothelin-1-like immunoreactivity in postobstructive pulmonary vasculopathy. J Vasc Res 1993a;30:333-338.
74. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Path FC, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Eng J Med 1993b;328:1732-1739.
75. Goerre S, Wenk M, Bartsch P, Luscher TF, Niroomand F, Hohenhaus E, Oelz O, Reinhart WH. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 1995;91:359-364.
76. Golden CL, Kohler JP, Nick HS, Visner G.A. Effects of vasoactive and inflammatory mediators on endothelin-1 expression in pulmonary endothelial cells. Am J Respir Cell Mol Biol 1995;12:503-512.
77. Gray GA, Löffler BM, Clozel M. Characterization of endothelin receptors mediating contraction of the rabbit saphenous vein. Am J Physiol 1994;266:H959-H966.
78. Gray GA, Webb DJ. Molecular Biology and Pharmacology of the Endothelins. Heidelberg: Springer-Verlag, 1995:1-173.
79. Halm AW, Resink TJ, Scott-Burden T Powell J, Dohi Y, Bühler FR. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regulation 1990;1:649-659.
80. Harrison VJ, Corder R, Änggård EE, Vane JR. Evidence for vesicles that transport endothelin-1 in bovine aortic endothelial cells. J Cardiovasc Pharmacol 1993;22(8):S57-S60.
81. Hasleton PS, Ironside JW, Whittaker JS, Kelly W, Ward C, Thompson GS. Pulmonary veno-occlusive disease. A report of four cases. Histopathology 1986;10:933-944.
82. Hasunuma K, Rodman DM, O'Brien RF, McMurtry IF. Endothelin-1 causes pulmonary vasodilatation in rats. Am J Physiol 1990;259:H48-54.
83. Hatakeyama H, Miyamori I, Yamagishi S, Takeda Y, Takeda R, Yamamoto H. Angiotension II up-regulates the expression of type A endothelin receptor in human vascular smooth muscle cells. Biochem Mol Biol Int 1994;34:127-134.
84. Hattori Y, Kasai K, Banba N, Hattori S, Nakamura T, Shimoda S. Effect of a phorbol ester on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Endocrinol Jpn 1992;39:341-345.
85. Haworth SG. Pulmonary hypertension in childhood: clinico-pathological correlations. In: Morice AH ed. Clinical pulmonary hypertension. London: Portland press 1995:11-42.
86. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994:344:852-854.
87. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary artery with special reference to congenital cardiac septal defect. Circulation 1958;18:533-547.
88. Hemsén A. Biochemical and functional characterization of endothelin peptides with special reference to vascular effects. Acta Phys Scand 1991;142(Suppl 602):1-61.
89. Hemsén A, Franco-Cereceda A, Matran R, Rudehill A, Lundber JM. Occurrence, specific binding sites and functional effects of endothelin in human cardiopulmonary tissue. Eur J Pharmacol 1990;191:319-328.
90. Hickey KA, Rubanyi G, Paul RJ, Highsmith RF. Characterisation of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol 1985;248:C550-C556.
91. Hieda HS, Gomez-Sanches CE. Hypoxia increases endothelin release in bovine endothelial cells in culture, but epinephrine, norepinephrine, serotonin, histamine and angiotensin II do not. Life Sci 1990;47:247-251.
92. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F, Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993;91:1367-1373..
93. Hirata Y, Yoshimi H, Takaichi S, Yanagisawa M, Masaki T. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS L 1988;239(1):13-17.
94. Hori S, Komatsu Y, Shigemoto R, Mizuno N, Nakanishi S. Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 1992;130:1885-1895.
95. Hosoda K, Nakao K, Tamura N, Arai H, Ogawa Y, Suga S-I, Nakanishi S, Imura H. Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor. J Biol Chem 1992;267:18797-18804.
96. Hughes JMP. In: Crystal RG, West JB ed. The Lung: Scientific Foundations. New York: Raven press 1991:1147-1161.
97. Högestätt ED, Andersson KE, Edvinsson L. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Phys Scand 1983;117:49-61.
98. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension. 1992;19:753-757.
99. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci 1989;86:2863-2867.
100. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea-pig atria. Am J Physiol 1988;255:H970-H973.
101. Jackman HL, Morris PW, Deddish PA, Skidgel RA, Erdos EG. Inactivation of endothelin I by deamidase (lysosomal protective protein). J Biol Chem 1992;267:2872-2875.
102. Kagamu H, Suzuki T, Arakawa M, Mitsui Y. Low oxygen enhances endothelin-1 (ET-1) production and responsiveness to ET-1 in cultured cardiac myocytes. Biochem Biophys Res Commun 1994;202:1612-1618.
103. Karamsetty VS, MacLean MR, McCulloch KM, Kane KA, Wadsworth RM. Hypoxic constrictor response in the isolated pulmonary artery from chronically hypoxic rats. Resp Physiol 1996;105:85-93.
104. C receptor) from Xenopus laevis dermal melanophores. J Biol Chem 1993;268:19126-19133.
105. Kasuya Y, Dobayashi H, Uemura H. Endothelin like immunoreactivity in the nervous system of invertebrates and fish. J Cardiovasc Pharmacol 17 1991:Suppl 7:S463-S466.
106. Katsuki S, Arnold W, Mittal C, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 1977;3:23-35.
107. Katzenstein AA, Askin FB. Pulmonary hypertension and other vascular disorders. In: Surgical pathology of non-neoplastic lung disease. Philadelphia: WB Saunders (2 ed) 1990:432-467.
108. Kaul TK, Bain WH, Jones JC, Lorimer AK, Thompson RM, Turner MA ,Escarous A. Mitral valve replacement in the presence of severe pulonary hypertension. Thorax 1976;31:332-336.
109. Kay JM, Smith P, Heath D. Aminorex and the pulmonary circulation. Thorax 1971:26:262-270.
110. Kiowski W, Sütsch G, Hunziker P, Müller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 1995;346:732-736.
111. Kirschbom PM, Tsui SSL, DiBernardo LR, Meliones JN, Schwinn DA, Ungerlieder RM, Gaynor JW. Blockade of endothelin-converting enzyme reduces pulmonary hypertension after cardiopulmonary bypass and circulatory arrest. Surgery 1995;118:440-445.
112. Kitamura K, Tanaka T, Kato J, Eto T, Tanaka K. Regional distribution of immunoreactive endothelin in porcine tissue: abundance in inner medulla of kidney. Biochem Biophys Res Comm 1989;161:348-352.
113. Kloog Y, Sokolovsky M. Similarities in mode and sites of action of sarafotoxins and endothelins. Trends Pharmacol Sci 1989;10:212-214.
114. Knothe C, Boldt J, Zickmann B, Ballesteros M, Dapper F, Hempelmann G. Endothelin plasma levels in old and young patients during open heart surgery: correlations to cardiopulmonary and endocrinology parameters. J Cardiovasc Pharmacol 1992;20:664-670.
115. Kohno M, Horio T, Ikeda M, Yokokawa K, Fukui T, Yasunari K, Kurihara N, Takeda T. Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int 1992;42:860-866.
116. Komai H, Adatia IT, Elliott MJ, De Leval MR, Haworth SG. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg 1993;106:473-478.
117. Komuro I. Kurihara H. Sugiyama T. Yoshizumi M. Takaku F. Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Letters 1988;238:249-252.
118. Koseki C, Imai M, Hirata Y, Yanagisawa M, Masaki T. Binding sites for endothelin-1 in rat tissues: an autoradiographic study. J Cardiovasc Pharmacol 1989;13:S153-154.
119. Kourembanas S, Marsden PA,. McQuillian LP,. Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991;88:1054-1057.
120. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993;92:99-104.
121. Kuchan MJ, Frangos JA. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 1993;264:H150-H156.
122. Kumar C, Mwangi V, Nuthulaganti P, Wu HL, Pullen M, Brun K, Aiyar H, Morris RA, Naughton R, Nambi P. Cloning and characterization of a novel endothelin receptor from Xenopus heart. J Biol Chem 1994;269:13414-13420
123. Langleben D, Cernacek P, Stewart DJ. Moderate hypoxia and hyperoxia do not alter endothelin release from bovine pulmonary endothelium in vitro. Circulation 1989;80:II288A.
124. Lazor R, Fehl F, Waeber B, Kucera P, Perret C. Endothelin-1 does not mediate the endothelium hypoxic contractions of small pulmonary arteries in rats. Chest 1996;110:189-197.
125. Leffler CW, Hessler JR and Green RS. The onset of breathing at birth stimulates pulmonary vascular prostacyclin synthesis. Paed Res 1984;18:938-942.
126. Levin ER. Endothelins. N Engl J Med. 1995;33:356-363.
127. Li H, Chen SJ, Chen YF, Meng QC, Durand J, Oparil S, Elton TS. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol 1994a;77:1451-1459.
128. Li H, Elton TS, Chen YF, Oparil S. Increased endothelin receptor gene expression in hypoxic rat lung. Am J Physiol 1994b;266:L553-560.
129. Lincoln TM. Cyclic GMP and mechanisms of vasodilation. Pharmac Therap 1989;41:479-502.
130. Lippton HL, Cohen GA, McMurtry IF, Hyman, AL. Pulmonary vasodilatation to endothelium isopeptides in vivo is mediated by potassium channel activation. J Appl Physiol 1991;70: 947-952.
131. Liu JJ, Casley DJ, Nayler WG. Ischaemia causes externalization of endothelin-1 binding sites in rat cardiac membranes. Biochem Biophys Res Commun 1989;164:1220-1225.
132. Liu S, Crawley DE, Barnes PJ, Evans TW. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis 1991;143:32-37.
133. Llorens-Cortes C, Huang H, Vicart P, Gasc JM, Paulin D, Corvol P. Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins. J Biol Chem 1992;267:14012-14018
134. Lüscher TF. Platelet-vessel wall interaction: role of nitric oxide, prostaglandins and endothelins. Baillieres Clin Haematol 1993;6:609-27.
135. Magee F, Wright JL, Wiggs BR, Pare PD, Hogg JC. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax 1988;43:183-189.
136. Mattoli S, Mezzetti M, Riva G, Allegra L, Fasoli A. Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin-like material from bronchial epithelial cells. Am J Respir Cell Molecul Biol 1990;3:145-151.
137. 2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochein Biophys Res Commun 1989;164:678-685.
138. McKay KO, Black JL, Diment LM, Armour CL. Functional and autoradiographic studies of endothelin-1 and endothelin-2 in human bronchi, pulmonary arteries, and airway parasympathetic ganglia. J Cardiovasc Pharmacol 1991;17:S206-209.
139. Michael JR, Markewitz BA. Endothelins and the lung. Am J Respir Critic Care Med 1996;154:555-581.
140. Michelakis ED. Archer SL. Weir EK. Acute hypoxic pulmonary vasoconstriction: a model of oxygen sensing. Physiol Res 1995;44:361-367.
141. Miller WL, Redfield MM, Burnett JC Jr,. Integrated cardiac renal and endocrine actions of endothelin. J Clin Invest 1989;83:317-320.
142. Mitaka C, Hirata Y, Nagura T, Tsunoda Y, Amaha K. Circulating endothelin-1 concentrations in acute respiratory failure. Chest 1993;104:476-480.
143. Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 1993;73:887-897.
144. Mizuno T, Imai T, Itakura M, Hirose S, Hirata Y, Marumo F, Hagiwara H. Structure of the bovine endothelin-B receptor gene and its tissue-specific expression revealed by northern analysis. J Cardiovasc Pharmacol 1992;20(Suppl 12):S8-10.
145. Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, Davenport AP. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res. 1993;72:526-538.
146. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that transforms platelet aggregation. Nature 1976; 263:663-665.
147. Moreau P, Takase H, Lüscher TF. Effect of endothelin antagonists on the responses to prostanoid endothelium-derived contracting factor. Br J Pharmacol 1996;118:1429-1432.
148. Morita T, Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 1995;96:2676-2682.
149. Morrison GW, Macartney FJ. Determinants of systemic vascular resistance in children with congenital heart disease. Cardiovasc Res 1981;15:245-253.
150. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessels thromboenibolic pulmonary hypertension. Chest 1993;103:685-692.
151. O'Brien RF, McMurtry IF. Endothelial cell supernatants contract bovine pulmonary artery rings. Am Rev Resp Dis 1984;129:A337.
152. Oakley CM. Investigations and diagnosis of pulmonary hypertension in adults. In: Morice AH ed. Clinical pulmonary hypertension. London: Portland press 1995:81-113.
153. Ogawa Y, Nakao K, Arai H, Nakagawa O, Hosoda K, Suga S, Nakanishi S, Imura H. Molecular cloning of a non-isopeptide-selective human endothelin receptor. Biochem Biophys Res Commun 1991;178:248-255.
154. Ohlstein EH, Arleth A, Ezekiel M, Horohonich S, Ator MA, Caltabiano MM, Sung CP. Biosynthesis and modulation of endothelin from bovine pulmonary arterial endothelial cells. Life Sci 1990;46:181-188.
155. Okada K, Miyazaki Y, Takada J, Matsuyama K, Yamaki T, Yano M. Conversion of big endothelin-1 by membrane-bound metalloendopeptidase in cultured bovine endothelial cells. Biochem Biophys Res Commun 1990;171:1192-1198.
156. Okada M, Yamashita C, Okada M, Okada K. Role of endothelin-1 in beagles with dehydromonocrotaline-induced pulmonary hypertension. Circulation 1995a;92:114-119.
157. Okada M, Yamashita C, Okada M, Okada K.. Endothelin receptor antagonists in a beagle model of pulmonary hypertension: contribution to possible potential therapy? J Am Coll Cardiol 1995b;25: 1213-1217.
158. Oliver FJ, de la Rubia G, Feener EP, Lee ME, Loeken MR, Shiba T, Quertermous T, King GL. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem 1991;266:23251-23256.
159. Ono K, Tsujimoto G Sakamoto A, Eto K, Masaki T, Ozaki Y, Satake M. Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature 1994;370:301-304.
160. Oparil S, Chen SJ, Meng QC, Elton TS, Yano M, Chen YF. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat. Am J Physiol 1995;268:L95-100.
161. Opgenorth T, Wu Wong JR, Shiosaki K. Endothelin-converting enzymes. FASEB J 1992;6:2653-2659.
162. Pääkkö P, Suntinen S, Remes M, Paavilainen T, Wagenvoort CA. A case of pulmonary vascular oclusive disease: comparison of post-mortem radiography and histology. Histophatology 1985;9: 253-262.
163. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;372:524-526.
164. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338:1173-1174.
165. Pernow J, Hemsen A, Lundberg JM. Tissue specific distribution, clearance and vascular effects of endothelin in the pig. Biochem Biophys Res Commun 1989;161:647-653.
166. Pernow J, Kaijser L, Lundberg JM, Ahlborg G. Comparable potent coronary constrictor effects of endothelin-1 and big endothelin-1 in humans. Circulation 1996;94:2077-2082.
167. Perreault, T, Stewart DJ, Cernacek P, Wu X, Ni F, De Marte J, Giaid A. Newborn piglet lung releases endothelin-1: effect of thrombin and hypoxia. Can J Physiol Pharmacol 1993;71:227-233.
168. Plevin R, Kellock NA, Wakelam MJ, Wadsworth R. Regulation by hypoxia of endothelin-1-stimulated phospholipase D activity in sheep pulmonary artery cultured smooth muscle cells. Br J Pharmacol 1994;112:311-315.
169. Prins BA, Hu RM, Nazario B, Pedrani A, Frank HJ, Weber MA, Levin ER. Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem 1994;269:11938-11944.
170. Rabinovitch M. Prostaglandins and structural changes in pulmonary arteries. Am Rev Respir Dis 1987;136:777-779.
171. Radomski MW. Palmer RM. Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990;87:10043-10047.
172. Ray SG, McMurray JJ, Morton JJ, Dargie HJ. Circulating endothelin is not extracted by the pulmonary circulation in man. Chest ;1992:102:1143-1144.
173. Reeves JT, Dempsey JA, Grover RF. Pulmonary circulation during exercise. In: Weir EK, Reeves JT, ed. Pulmonary Vascular Physiology and Pathophysiology. New York: Marcel Dekker Inc, 1989;38:107-134.
174. Reeves JT, Durmowitz AG, Weizer MC, Orton EC, Stenmark KR. Diversity in the pulmonary circulation: an overview of the international conference on the pulmonary vasculature in health and disease. Eur Respir Rev 1993;3:530-534.
175. Resink TJ, Scott-Burden T, Boulanger C, Weber E, Buhler FR. Internalization of endothelin by cultured human vascular smooth muscle cells, characterization and physiological significance. Mol Pharmacol 1990;38:244-252.
176. Robin ED, Thedore J, Burke CM, Oesterle SN, Fowler MB, Jamieson SW, Baldwin JC, Morris AJ, Hunt SA, Vankessel et al., Hypoxic pulmonary vasoconstriction persists in the human transplanted lung. Clin Sci 1987;72:283-287.
177. Roupert P, Gillard V, Plas P, Chabrier PE, Braquet P. Binding characteristics of endothelin isoforms (ET-1, ET-2, ET-3) in vascular smooth muscle cells. J Cardiovasc Pharmacol 1991:17 (Suppl 5):S104-S108.
178. Saijonmaa O, Nyman T, Fyhrquist F. Endothelin-1 stimulates its own synthesis in human endotlielial cells. Biochem Biophys Res Commun 1992;188:286-91.
179. Sakai S, Miyauchi T, Sakurai T, Yamaguchi I, Kobayashi M, Goto K, Sugishita Y. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats. J Am Coll Cardiol 1996;28:1580-1588.
180. Sakurai T, Yanagisawa M, Takauwa Y, Miyazaki, H, Kimura S, Goto K, Masaki T. Cloning of cDNA encoding a nonisopeptide selective subtype of the endothelin receptor. Nature 1990;348:732-735.
181. B blockade on ET-1-induced constriction in perfused rat lungs. Am J Physiol 1995;269:L668-672.
182. Schersten H, Kirno K, Ekroth R, Lundin S, Pettersson A, Kjellström C, Miller VM, Nilsson F. Impaired endothelium-mediated vasodilatation in the peripheral vasculature of patients with acute pulmonary allograft rejection. J Heart Lung Transpl 1996;15:556-563.
183. Scott PH, Peacock AJ. Cell signalling in pulmonary vascular cells: do not shot the messenger. Thorax 1996;51:864-866.
184. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994;89:1203-1208.
185. Shimada K, Matsushita Y, Wakabayashi K, Takahashi M, Matsubara A, Iijima Y, Tanzawa K. Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem Biophys Res Commun. 1995a;207:807-812.
186. Shimada K, Takahashi M, Ikeda M, Tanzawa K. Identification and characterization of two isoforms of an endothelinconverting enzyme-1. FEBS Lett 1995b;371:140-144.
187. Shirakami G, Nakao K, Saito Y, Magaribuchi T, Jougasaki M, Mukoyama M, Arai H, Hosoda K, Suga S, Ogawa Y, Yamada T, Mon K, Imura H. Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 in conscious rats. Life Sci 1991;48:969-976.
188. Simonson MS, Dunn MJ. Cellular signaling by peptides of the endothelin gene family. FASEB J 1993;4:2829-3000.
189. Sliwinski P, Hawrylkiewicz I, Gorecka D, Zielinski J. The acute effect of oxygen on pulmonary arterial pressure does not predict survival on long-term oxygen therapy in COPD patients. Monaldi Arch Chest Dis 1993;48:451-452.
190. Stelzner TJ, O'Brien RF, Yanagisawa M, Sakurai T, Sato K, Webb S, Zamora M, McMurtry IF, Fisher JH. Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am J Physiol 1992;262:L614-L640.
191. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma levels of endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Int Med 1991;114:464-469.
192. Stewart S. The pathology of lung transplantation. Semin Diagnostic Pathol 1992;9:210-219.
193. Suzuki T, Hoshi H, Mitsui Y. Endothelin stimulates hypertrophy and contractility of neonatal rat cardiac myocytes in a serum-free medium. FEBS L 1990;268:149-151.
194. Takeda Y, Itoh Y, Yoneda T, Miyamori I, Takeda R. Cyclosporine A induces endothelin-1 release from cultured rat vascular smooth muscle cells.Eur J Pharmacol 1993;233:299-301.
195. Takeoka M, Ishizaki T, Sakai A, Chang SW, Shigemori K, Higashi T, Ueda G. Effect of BQ-123 on vasoconstriction as a result of either hypoxia or endothelin-1 in perfused rat lungs. Acta Physiol Scand 1995;155:53-60.
196. Takigawa M, Sakurai T, Kasuya Y, Abe Y, Masaki T, Goto K. Molecular identification of guanine-nucleotide-binding regulatory proteins which couple to endothelin receptors. Eur J Biochem 1995;228:102-108.
197. Tenney SM. Phylogenetic perspective on control of the pulmonary circulation. In: Weir EK and Reeves JT, ed. Pulmonary Vascular Physiology and Pathophysiology. New York: Marcel Dekker Inc, 1989:3-25.
198. Wagenvoort CA. Pathology of congestive pulmonary hypertension. Prog Respir Res 1975;9:195-202.
199. Wagenvoort CA. Grading of pulmonary vascular lesions - a reappraisal. Histopathology 1981;5:595-598.
200. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhäusl W, Binder BR. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-16068.
201. Walker BR, Voelkel NF, Reeves JT. Pulmonary pressor response after prostaglandin synthesis inhibition in conscious dogs. J Appl Physiol 1982;52:705-709.
202. Vane JR, Ängård EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
203. Wang Y, Coe Y, Toyoda O, Coceani F. Involvement of endothelin-1 in hypoxic pulmonary vasoconstriction in the lamb. J Physiol 1995;482:421-434.
204. Wang Y, Rose PM, Webb ML, Dunn MJ. Endothelins stimulate mitogen-activated protein kinase cascade through either ETA or ETB. Am J Physiol 1994;267:1130-1135.
205. Vanhoutte PM, Auch-Schwelk W, Boulanger C, Janssen PA, Katusic ZS, Komori K, Miller VM, Schini VB, Vidai M. Does endothelin-1 mediate endothelium-dependent contractions during anoxia? J Cardiovasc Pharmacol 1989;13:S124-128.
206. Ward JP, Robertson TB. The role of the endothelium in hypoxic pulmonary vasoconstriction. Exp Physiol 1995;80:793-801.
207. Warner TD, Allcock GH, Mickley EJ, Vane JR. Characterization of endothelin receptors mediating the effects of the endothelin/sarafotoxin peptides on autonomic neurotransmission in the rat vas deferens and guinea-pig ileum. Br J Pharmacol 1993;110:783-9.
208. A receptor antagonist. J Pharmacol Exp Therap 1995a;272: 1124-1134.
209. B -selective antagonist IRL 2500 in concious spontaneously hypertensive and Wistar-Kyoto rats. J Cardiovasc Pharmacol 1995b;26:S389-392.
210. Weir EK, Grover RF. The role of endogenous prostaglandins in the pulmonary circulation. Anesthesiology 1978;48:201-212.
211. Weitzberg E, Rudehill A, Modin A, Lundberg JM. Porcine intrinsic pulmonary and systemic vascular tone is endothelin-dependent. Acta Phys Scand 1994;152:433-434.
212. Weitzberg E. Circulatory responses to endothelin-1 and nitric oxide with special reference to endotoxin shock and nitric oxide inhalation. Acta Physiol Scand 1993;148(Suppl 661):1-72.
213. Veniant M, Clozel JP, Hess P, Clozel M. Endothelin plays a role in the maintenance of blood pressure in normotensive guinea-pigs. Life Sciences 1994;55:445-454.
214. White FN. Redistribution of cardiac output in the diving alligator. Copeia 1969;3:567-570.
215. Whittle BJR, Lopez-Belmonte J, Rees DD, Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol 1989;98:646-652.
216. Wiebke JL, Montrose-Rafizadeh C, Zeitlein PL, Guggino WB. Effect of hypoxia on endothelin-1 production by pulmonary vascular endothelial cells. Biochim Biophys Acta 1992;1134:105-111.
217. Wilkes LC, Patel V, Purkiss JR, Boarder MR. Endothelin-1 stimulated phospholipase D in A 10 vascular smooth muscle derived cells is dependent on tyrosine kinase. Evidence for involvement in stimulation of mitogenesis. FEBS L 1993;322:147-150.
218. Williams DL, Jones KL, Pettibone DJ, Lis EV, Clineschmidt BV. Sarafotoxin 6c: an antagonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 1991;175: 556-561.
219. Vincent JA, Ross, RD, Kassab J, Hsu JM, Pinsky WW. Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow. Am J Cardiol 1993;71:1204-1207.
220. Wong J, Vanderford PA, Findeman JR, Chan R, Soifer SJ. Endothelin-1 produces pulmonary vasodilatation in the intact newborn lamb. Am J Physiol 1993a;265:H1318-H1325.
221. Wong J, Vanderford PA, Winters JW, Chang R, Soifer SJ, Fineman JR. Endothelin-1 does not mediate acute hypoxic pulmonary hypertension in the intact newborn lamb. J Cardiovasc Pharmacol 1993b;22:S262-S266.
222. Yanagisawa M, Kiruhara H, Kimura S, Tomobe Y, Kobyashi M, Mitsui Y, Yazaki Y, Goto K and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
223. A gene. Biochem Biophys Res Commun. 1993;190:332-339.
224. Yorimitsu K, Moroi K, Inagaki N, Saito T, Masuda Y, Masaki T, Seino S, Kimura S. Cloning and sequencing of a human endothelin converting enzyme in renal adenocarcinoma cells (ACHN) producing endothelin-2. Biochem Biophys Res commun 1995;208:721-727.
225. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, Temma S, Shirakami G, Imura H, Mikawa H. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Circulation 1991;84:2280-2285.
226. Yoshimoto S, Ishizaki Y, Sasaki T, Murota S-I. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke 1991;22:378-383.
227. Yoshimura K, Kobayashi T, Kusama S, Sakai A, Ueda G. Thromboxane synthetase inhibition and pulmonary response to hypoxia in conscious adult sheep. Jap Circ J 1988;52:66-71.
228. Yoshizumi M. Kurihara H. Sugiyama T. Takaku F. Yanagisawa M. Masaki T. Yazaki Y. Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989;161:859-864.
229. 2 increases the vasoconstrictor effect of endothelin-1 in posrischemic reperfused rat hearts. Circulation 1996;94:742-747.
230. Zhang H, Inazu M, Weir B, Daniel E. Endothelin-1 inhibits inward rectifier potassium channels and activates nonspecific cation channels in cultured endothelial cells. Pharmacology 1994;49:11-22.
231. Zhu ZG, Wang M-S, Jiang Z-B, Jiang Z, Xu S-X, Ren C-Y, Shi M-X. The dynamic change of plasma endothelin-1 during the perioperative period in patients with rheumatic valvular desease and secondary pulmonary hypertension. J Thorac Cardiovasc Surg 1994;108:960-968.